These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25483077)

  • 1. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy.
    Yano S; Zhang Y; Zhao M; Hiroshima Y; Miwa S; Uehara F; Kishimoto H; Tazawa H; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2014; 13(24):3958-63. PubMed ID: 25483077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.
    Yano S; Takehara K; Zhao M; Tan Y; Han Q; Li S; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2016 Jul; 15(13):1715-23. PubMed ID: 27152859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methioninase Cell-Cycle Trap Cancer Chemotherapy.
    Hoffman RM; Yano S; Igarashi K
    Methods Mol Biol; 2019; 1866():133-148. PubMed ID: 30725413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmonella typhimurium A1-R and Cell-Cycle Decoy Therapy of Cancer.
    Hoffman RM; Yano S
    Methods Mol Biol; 2016; 1409():165-75. PubMed ID: 26846810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li S; Han Q; Tan Y; Zhao M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    Cell Cycle; 2018; 17(6):801-809. PubMed ID: 29374999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cells mimic in vivo spatial-temporal cell-cycle phase distribution and chemosensitivity in 3-dimensional Gelfoam® histoculture but not 2-dimensional culture as visualized with real-time FUCCI imaging.
    Yano S; Miwa S; Mii S; Hiroshima Y; Uehara F; Kishimoto H; Tazawa H; Zhao M; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2015; 14(6):808-19. PubMed ID: 25564963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.
    Yano S; Tazawa H; Hashimoto Y; Shirakawa Y; Kuroda S; Nishizaki M; Kishimoto H; Uno F; Nagasaka T; Urata Y; Kagawa S; Hoffman RM; Fujiwara T
    Clin Cancer Res; 2013 Dec; 19(23):6495-505. PubMed ID: 24081978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-cycle-dependent drug-resistant quiescent cancer cells induce tumor angiogenesis after chemotherapy as visualized by real-time FUCCI imaging.
    Yano S; Takehara K; Tazawa H; Kishimoto H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
    Cell Cycle; 2017 Mar; 16(5):406-414. PubMed ID: 27715464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.
    Yano S; Takehara K; Tazawa H; Kishimoto H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
    J Cell Biochem; 2017 Nov; 118(11):3635-3642. PubMed ID: 27171483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Cell-Cycle Decoying Killer Adenovirus on 3-D Gelfoam®-Histoculture and Tumor-Sphere Models of Chemo-Resistant Stomach Carcinomatosis Visualized by FUCCI Imaging.
    Yano S; Takehara K; Tazawa H; Kishimoto H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
    PLoS One; 2016; 11(9):e0162991. PubMed ID: 27673332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP).
    Miyake K; Kiyuna T; Miyake M; Zhao M; Wangsiricharoen S; Kawaguchi K; Zhang Z; Higuchi T; Razmjooei S; Li Y; Nelson SD; Russell T; Singh A; Murakami T; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Singh SR; Chawla SP; Eilber FC; Endo I; Hoffman RM
    Tissue Cell; 2018 Oct; 54():144-149. PubMed ID: 30309504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUCCI Real-Time Cell-Cycle Imaging as a Guide for Designing Improved Cancer Therapy: A Review of Innovative Strategies to Target Quiescent Chemo-Resistant Cancer Cells.
    Yano S; Tazawa H; Kagawa S; Fujiwara T; Hoffman RM
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32957652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.
    Miyake K; Murata T; Murakami T; Zhao M; Kiyuna T; Kawaguchi K; Igarashi K; Miyake M; Lwin TM; Hozumi C; Komatsu S; Kikuchi T; Bouvet M; Shimoya K; Singh SR; Endo I; Hoffman RM
    Arch Gynecol Obstet; 2019 Jun; 299(6):1683-1690. PubMed ID: 30953192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells.
    Hiroshima Y; Zhao M; Zhang Y; Maawy A; Hassanein MK; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    Cell Cycle; 2013 Sep; 12(17):2774-80. PubMed ID: 23966167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.
    Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for Tumor Targeting with Salmonella typhimurium A1-R.
    Hoffman RM; Zhao M
    Methods Mol Biol; 2016; 1409():143-64. PubMed ID: 26846809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model.
    Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Zhang Y; Zhao M; Li Y; Bouvet M; Kanaya F; Singh A; Dry S; Eilber FC; Hoffman RM
    Oncotarget; 2016 May; 7(22):33046-54. PubMed ID: 27105519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
    Hoffman RM
    Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeting
    Kiyuna T; Tome Y; Uehara F; Murakami T; Zhang Y; Zhao M; Kanaya F; Hoffman RM
    Anticancer Res; 2018 Jan; 38(1):159-164. PubMed ID: 29277768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future of Bacterial Therapy of Cancer.
    Hoffman RM
    Methods Mol Biol; 2016; 1409():177-84. PubMed ID: 26846811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.